Tag | Content |
---|
EnhancerAtlas ID | HS051-22222 |
Organism | Homo sapiens |
Tissue/cell | Fetal_thymus |
Coordinate | chr5:130713920-130716930 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
FOSL1 | MA0477.1 | chr5:130716118-130716129 | CATGAGTCACC | - | 6.62 | JUN | MA0488.1 | chr5:130715094-130715107 | GTGATGATGTAAT | + | 6.24 | JUND | MA0491.1 | chr5:130716118-130716129 | CATGAGTCACC | - | 6.02 | Nr2f6(var.2) | MA0728.1 | chr5:130716058-130716073 | TGAACTCCTGACCTC | - | 6.22 | STAT1 | MA0137.3 | chr5:130715483-130715494 | TTTCCAGGAAA | + | 6.62 |
|
| Number of super-enhancer constituents: 22 | ID | Coordinate | Tissue/cell |
SE_08647 | chr5:130712900-130715860 | Brain_Inferior_Temporal_Lobe | SE_10006 | chr5:130712844-130722567 | CD14 | SE_10385 | chr5:130712896-130718901 | CD19_Primary | SE_10907 | chr5:130699367-130735126 | CD20 | SE_11887 | chr5:130712858-130719687 | CD3 | SE_13026 | chr5:130713603-130717217 | CD34_Primary_RO01480 | SE_13506 | chr5:130712893-130720777 | CD34_Primary_RO01536 | SE_14138 | chr5:130712973-130718650 | CD34_Primary_RO01549 | SE_15367 | chr5:130713103-130720778 | CD4_Memory_Primary_7pool | SE_15753 | chr5:130712912-130719330 | CD4_Memory_Primary_8pool | SE_16549 | chr5:130713670-130719295 | CD4_Naive_Primary_8pool | SE_16976 | chr5:130713097-130719753 | CD4p_CD225int_CD127p_Tmem | SE_17396 | chr5:130704663-130724162 | CD4p_CD25-_CD45RAp_Naive | SE_17877 | chr5:130712828-130722996 | CD4p_CD25-_CD45ROp_Memory | SE_18240 | chr5:130702811-130733677 | CD4p_CD25-_Il17-_PMAstim_Th | SE_19429 | chr5:130712817-130721459 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_20530 | chr5:130712829-130719785 | CD56 | SE_22253 | chr5:130713002-130719685 | CD8_Naive_8pool | SE_22345 | chr5:130712803-130721212 | CD8_primiary | SE_59171 | chr5:130708263-130734786 | Ly3 | SE_61342 | chr5:130707087-130732769 | HBL1 | SE_62559 | chr5:130690812-130733307 | Tonsil |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr5 | 130716109 | 130716219 | chr5 | 130715394 | 130715800 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH05I131373 | chr5 | 130708017 | 130720831 |
|
Enhancer Sequence | ACTACCATAA AAGGTATTTT CATTTTTTGT GTCAATGAAT ATCCACTAGG AAGATCATTT 60 TCATCAAAAA ATGTCAAATC CATTTTTTAT ATTATTACAA CTTTTGTTAG CCTTTTTTTC 120 CATACTGTGA ACTAGATTGA TTAACTTGGA AGCAGCTCAC GCACCCAGGG AATCACTGTC 180 ACTGGCATCA TAGAAAAAAA ATACCCACTT GTTTTAGAAA TGCCTGGTTC CTAATTACAC 240 TGTCAATATT TCAAAAAACT AATGTAGCTT ATTTCAGAGG TTCCCAAACT TCTCTTAACG 300 GTTCTGTAAT TTTTTTCATG GTGCCTCTAG GCCAAGAGAA ATACCGTACA GACTTGTTTA 360 TTAACTAATT TGGTACAAAC AACTTAGTAA AGATTTATGT CCCAACAACT TATTTGCCTT 420 TAAAAAATAA GATATAAATT GAAAAATATT TTTATTTAAT TCTTAAATAA CCAGTTACAT 480 ACTTATGGTG TGTTTGTGCC TGTTGGGATT ATACAACTTC TCAAACTGTG GAATCAGACT 540 GAACACCACC ACCTTCTTTT CTAGTTCCAT ACTGACTTTT GCATAGTGCT TGGGTTTTTT 600 TCACAGTAAC CACTGAAAAC TCAGCTTCAC AAAGATATGC TGTTAAAAAG AATGTATGTT 660 CTAATGTTGA AGTTACAAAT TATCTGAAGC TGGTAGTTCA CTCAGTGTCA AACACACATT 720 GAGCCTCACT GTGTTTCCCT CAAATAGAAA ACCCTGGCAC CCCTGGGTTT TGCTGGGATG 780 CCCCAAGACA CAATTTGGAA ATAGTGGGCT TGTTAGATTT AATTCATAGA TTTAGGGATT 840 TAGTTACACA ACTCAACTGA CTTTCTCTAG GTCATAAAGT TGAGTCAGCA TAGCTTTCAA 900 CCTTTCATTT ACTTTGGCCA CATTTGCATA AATGATTGCT ATTTTATACC CTGAAAGTTC 960 CAGCTTTTTT CACTGTCCCA GATGGCAAGT ATTTTCATTT TCTTTATTCA CTCTGTATCT 1020 GCTTCTAGAA CTACCTCAGG CTGTACCATC TTTTACTCTT ACTGTAGGCC TTCTGCTAAC 1080 CTGATGGGAC CTGGCCTTCA TTTGCTTCTC AGTGACATGT GTTTGCACAC TAAGCTGCCC 1140 AGAGAATAGT CTTTGGGAAA GTTTTAACTT TTAAGTGATG ATGTAATTAC TGTTTTCTAG 1200 AAGCTACAGT TGATCCATAT GCCAGAAATG TGAGGGAGGT AGATATAGTA TGGTTATATA 1260 CATATTGTTT AGATAAGGAT GCAAATAAGG TTCTCACAGT AGCAAATCCT TTGAAATTAA 1320 CCTGCTTCTC GCCTCCTTGG ATATACTCCA AATTGTTTAG TTCATTATCT TTAATAATTA 1380 TGATGTAATT ATGTAAAAAG TTATGGGAAG AGACATTTTG CCTAATGTCC CCTCCACACT 1440 AACATAGCAG TTCATTTGGG TCTCTAGTCC TTCACCTTAT GCAGAATAAA AGTTAATATT 1500 TTAAGGATGC AAGGATTATT CAGATGGTTG ACGGTCTTAA CAAAGTTTCC TATAAAGAAT 1560 TTGTTTCCAG GAAACACGGT GACTCTGCTA ACGACAACTG TTAATACGTA TCAGAGCAGA 1620 GTGCACCATT TCCTGTTTTT CTTTGCGGAG GTCTGACTCT GGAATTCCCC TTGTTTGCCC 1680 ATGACTATTC TTTTTTTTTC TTTTGAAACA GAGTCTCACT CTGGCACCCA GGCTGGAGTG 1740 CAGTGGTGTG ATCTCGGCTC ACTGCAACCT CTCCCCGCCA ACCCCCCACC CCAGGTTCAA 1800 GTGATTCTTC TGCCTCAGCC TCTCAAGTAG CTGGGATTAC AGGTGCCTGC CACCATGCCC 1860 AGCTAATTTT TTTTTCTTAA AGAAAATATT TAATTTTCCA TAGTTATTGG GGCTACAGGT 1920 GGTGTTTGGT TACATGAGTA AGTTCTTTAG TGGTGATTTG TGGATTTTGG TGTACTCATC 1980 ACCCGAGCAG TGTACACTGC ACCATATTTG TAGTCTTTTA TAAAACCCTT GCCCCCCTCC 2040 CACTCTTCCA GAGCCCCAAG TCCATTTGAT CATTCTTATG GCCTAATTTT TGTATTTTTA 2100 GTGGAGACAG GGTTTCGCCA TGTTGGCCAG GCTGGTCTTG AACTCCTGAC CTCAAGTGAT 2160 CCACCTGCCT CAGCCTCCTG AAGTGCTGGG ATTATAGGCA TGAGTCACCA TGCCCAGCCA 2220 CCCGTGACTA TTATACAGTA CCCCAAACAA GTGTGCCATT CTTTAAATGT CCACATTGTG 2280 CCTTAAAATA CTGCATTTTT ATAGTTTAGA ATATTTATTT ATATTTAAAT CCAGGTTTTT 2340 GATAGAGTGT TGTAGGAAAG AGTGTAAAGA ACACTTCCAC CTGTGTCTAG ATCCACCTTT 2400 CCTGCCTTCT CAGGAACCTT GTAAGGTTGA CAATCCATTT TCTTTTTCCT TCTTTTTCTG 2460 TACCTCTTTT ACTGGATCTT TCCCATTAGA AATTGAGCAT AATGAATTCT CTGCCATCTT 2520 ACAGGGGAAA AATTCAATCT GTTCTCATCT CCTTTTCTCC TTTCAGCCAC TGACCTGTCT 2580 TCTTCCTGTC CAGAAGGCCA GACTTTTCTC CAGAGTTGTC TCTGTTCTCT TTCTCCATTT 2640 TCCACTTCTT AGACCCACCT CAGTCCCCTG CAGCGTGTCT TCTCCTCCTA TTACTCCACT 2700 GACATAGCAC TCACTAAGGT GCCCATTGAC TTGATATTGC TGAATCCATT GCACGTATTT 2760 GTCTTTAATT GACCTCTCAC CACCTTTCAG CTCTGCTCCC TCTTGACACT TGTACACACT 2820 GCTGATTTTC CTACTGACTT TCAGGCTGTT TCTTTTTGGC CTTCTTTGAT GGCTTCTTCT 2880 CTGCCCAACC ACAGAAATTT AGTTTGTCTA GGAAATCTCA TTAACTTGGC TTTGTTAATG 2940 CTGGTGATTC TCAGTCTCTT ATCTCCAGTT TGGATTCTCT CAGAACCCAG TGAATTGCAC 3000 ACTCTCTGCT 3010
|